Interpretation of laboratory data and need for reference laboratories

Lupus

Volumn 21, Issue 7, 2012, Pages 732-733

  Pengo, V ^a   Denas, G ^a   Banzato, A ^a   Bison, E ^a   Bracco, A ^a   Visentin, M S ^a   Hoxha, A ^a   Ruffatti, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiphospholipid; diagnosis; laboratory

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTICOAGULATION; BLOOD CLOTTING TEST; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK PATIENT; HUMAN; LABORATORY TEST; PREGNANCY; PRIORITY JOURNAL; REFERENCE VALUE; THROMBOEMBOLISM;

ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REFERENCE STANDARDS;

EID: 84861567830     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312437271     Document Type: Conference Paper

References (13)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. De Laat B, Pengo V, Pabinger I, et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost. 2009 ; 7: 1767-1773
3. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost. 2005 ; 93: 1147-1152
4. De Laat B, Derksen RH, Urbanus RT, de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood. 2005 ; 105: 1540-1545
5. Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A, ; Italian Federation of Anticoagulation Clinics (FCSA) . Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2- Glycoprotein I activity. Thromb Res. 2007 ; 120: 127-133
6. Pengo V, Ruffatti A, Legnani C, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010 ; 8: 237-242
7. Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood. 2011 ; 118: 4714-4718
8. Pengo V, Biasiolo A, Rampazzo P, Brocco T. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-b2-glycoprotein i autoantibodies. Thromb Haemost. 1999 ; 81: 256-258
9. Banzato A, Pozzi N, Frasson R, et al. Antibodies to domain i of β2glycoprotein i are in close relation to patients risk categories in antiphospholipid syndrome (APS). Thromb Res. 2011 ; 128: 583-586
10. Witebsky E. Experimental evidence for the role of auto-immunization in chronic thyroiditis. Proc R Soc Med. 1957 ; 50: 955-958
11. Ruffatti A, Tonello M, Del Ross T, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost. 2006 ; 96: 337-341
12. Ruffatti A, Olivieri S, Tonello M, et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost. 2008 ; 8: 1693-1696
13. Pengo V, Biasiolo A, Gresele P, et al. Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost. 2007 ; 5: 925-930